No role for CXCL12-G801A polymorphism in the development of extramedullary disease in acute myeloid leukemia.
Ponziani
V
V
Mannelli
F
F
Bartalucci
N
N
Gianfaldoni
G
G
Leoni
F
F
Antonioli
E
E
Guglielmelli
P
P
Ciolli
S
S
Bosi
A
A
Vannucchi
A M
AM
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000483:Alleles; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D054377:Chemokine CXCL12 / Q000235:genetics* / Q000502:physiology; D018572:Disease-Free Survival; D005260:Female; D005838:Genotype; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000235:genetics* / Q000502:physiology; D020641:Polymorphism, Single Nucleotide; D016016:Proportional Hazards Models; D019718:Receptors, CXCR4 / Q000502:physiology; D012074:Remission Induction; D023981:Sarcoma, Myeloid / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D016019:Survival Analysis